Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula
- 1 May 2002
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 140 (5) , 547-554
- https://doi.org/10.1067/mpd.2002.123282
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Docosahexaenoic and Arachidonic Acid Prevent a Decrease in Dopaminergic and Serotoninergic Neurotransmitters in Frontal Cortex Caused by a Linoleic and α-Linolenic Acid Deficient Diet in Formula-fed PigletsJournal of Nutrition, 1999
- Human milk and formula fatty acidsThe Journal of Pediatrics, 1992
- Direct regulation of ion channels by fatty acidsTrends in Neurosciences, 1991
- Essential fatty acids in growth and developmentProgress in Lipid Research, 1991
- Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transductionBiochemical Society Transactions, 1990
- Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infantsEuropean Journal of Pediatrics, 1989
- Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formulaThe American Journal of Clinical Nutrition, 1986
- Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys.Proceedings of the National Academy of Sciences, 1986
- Essential fatty acid requirements in pregnancy and lactation with special reference to brain developmentProgress in Lipid Research, 1981
- Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirementsEarly Human Development, 1980